Cargando…
MALDI-TOF mass spectrometry for sub-typing of Streptococcus pneumoniae
BACKGROUND: Serotyping of Streptococcus pneumoniae is important for monitoring of vaccine impact. Unfortunately, conventional and molecular serotyping is expensive and technically demanding. This study aimed to determine the ability of matrix-assisted laser desorption-ionisation time-of-flight (MALD...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709296/ https://www.ncbi.nlm.nih.gov/pubmed/33261551 http://dx.doi.org/10.1186/s12866-020-02052-7 |
_version_ | 1783617719572103168 |
---|---|
author | Kann, Sivkheng Sao, Sena Phoeung, Chanleakhena By, Youlet Bryant, Juliet Komurian-Pradel, Florence Saphonn, Vonthanak Chou, Monidarin Turner, Paul |
author_facet | Kann, Sivkheng Sao, Sena Phoeung, Chanleakhena By, Youlet Bryant, Juliet Komurian-Pradel, Florence Saphonn, Vonthanak Chou, Monidarin Turner, Paul |
author_sort | Kann, Sivkheng |
collection | PubMed |
description | BACKGROUND: Serotyping of Streptococcus pneumoniae is important for monitoring of vaccine impact. Unfortunately, conventional and molecular serotyping is expensive and technically demanding. This study aimed to determine the ability of matrix-assisted laser desorption-ionisation time-of-flight (MALDI-TOF) mass spectrometry to discriminate between pneumococcal serotypes and genotypes (defined by global pneumococcal sequence cluster, GPSC). In this study, MALDI-TOF mass spectra were generated for a diverse panel of whole genome sequenced pneumococcal isolates using the bioMerieux VITEK MS in clinical diagnostic (IVD) mode. Discriminatory mass peaks were identified and hierarchical clustering was performed to visually assess discriminatory ability. Random forest and classification and regression tree (CART) algorithms were used to formally determine how well serotypes and genotypes were identified by MALDI-TOF mass spectrum. RESULTS: One hundred and ninety-nine pneumococci, comprising 16 serotypes and non-typeable isolates from 46 GPSC, were analysed. In the primary experiment, hierarchical clustering revealed poor congruence between MALDI-TOF mass spectrum and serotype. The correct serotype was identified from MALDI-TOF mass spectrum in just 14.6% (random forest) or 35.4% (CART) of 130 isolates. Restricting the dataset to the nine dominant GPSC (61 isolates / 13 serotypes), discriminatory ability improved slightly: the correct serotype was identified in 21.3% (random forest) and 41.0% (CART). Finally, analysis of 69 isolates of three dominant serotype-genotype pairs (6B-GPSC1, 19F-GPSC23, 23F-GPSC624) resulted in the correct serotype identification in 81.1% (random forest) and 94.2% (CART) of isolates. CONCLUSIONS: This work suggests that MALDI-TOF is not a useful technique for determination of pneumococcal serotype. MALDI-TOF mass spectra appear more associated with isolate genotype, which may still have utility for future pneumococcal surveillance activities. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-020-02052-7. |
format | Online Article Text |
id | pubmed-7709296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77092962020-12-02 MALDI-TOF mass spectrometry for sub-typing of Streptococcus pneumoniae Kann, Sivkheng Sao, Sena Phoeung, Chanleakhena By, Youlet Bryant, Juliet Komurian-Pradel, Florence Saphonn, Vonthanak Chou, Monidarin Turner, Paul BMC Microbiol Research Article BACKGROUND: Serotyping of Streptococcus pneumoniae is important for monitoring of vaccine impact. Unfortunately, conventional and molecular serotyping is expensive and technically demanding. This study aimed to determine the ability of matrix-assisted laser desorption-ionisation time-of-flight (MALDI-TOF) mass spectrometry to discriminate between pneumococcal serotypes and genotypes (defined by global pneumococcal sequence cluster, GPSC). In this study, MALDI-TOF mass spectra were generated for a diverse panel of whole genome sequenced pneumococcal isolates using the bioMerieux VITEK MS in clinical diagnostic (IVD) mode. Discriminatory mass peaks were identified and hierarchical clustering was performed to visually assess discriminatory ability. Random forest and classification and regression tree (CART) algorithms were used to formally determine how well serotypes and genotypes were identified by MALDI-TOF mass spectrum. RESULTS: One hundred and ninety-nine pneumococci, comprising 16 serotypes and non-typeable isolates from 46 GPSC, were analysed. In the primary experiment, hierarchical clustering revealed poor congruence between MALDI-TOF mass spectrum and serotype. The correct serotype was identified from MALDI-TOF mass spectrum in just 14.6% (random forest) or 35.4% (CART) of 130 isolates. Restricting the dataset to the nine dominant GPSC (61 isolates / 13 serotypes), discriminatory ability improved slightly: the correct serotype was identified in 21.3% (random forest) and 41.0% (CART). Finally, analysis of 69 isolates of three dominant serotype-genotype pairs (6B-GPSC1, 19F-GPSC23, 23F-GPSC624) resulted in the correct serotype identification in 81.1% (random forest) and 94.2% (CART) of isolates. CONCLUSIONS: This work suggests that MALDI-TOF is not a useful technique for determination of pneumococcal serotype. MALDI-TOF mass spectra appear more associated with isolate genotype, which may still have utility for future pneumococcal surveillance activities. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-020-02052-7. BioMed Central 2020-12-01 /pmc/articles/PMC7709296/ /pubmed/33261551 http://dx.doi.org/10.1186/s12866-020-02052-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Kann, Sivkheng Sao, Sena Phoeung, Chanleakhena By, Youlet Bryant, Juliet Komurian-Pradel, Florence Saphonn, Vonthanak Chou, Monidarin Turner, Paul MALDI-TOF mass spectrometry for sub-typing of Streptococcus pneumoniae |
title | MALDI-TOF mass spectrometry for sub-typing of Streptococcus pneumoniae |
title_full | MALDI-TOF mass spectrometry for sub-typing of Streptococcus pneumoniae |
title_fullStr | MALDI-TOF mass spectrometry for sub-typing of Streptococcus pneumoniae |
title_full_unstemmed | MALDI-TOF mass spectrometry for sub-typing of Streptococcus pneumoniae |
title_short | MALDI-TOF mass spectrometry for sub-typing of Streptococcus pneumoniae |
title_sort | maldi-tof mass spectrometry for sub-typing of streptococcus pneumoniae |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709296/ https://www.ncbi.nlm.nih.gov/pubmed/33261551 http://dx.doi.org/10.1186/s12866-020-02052-7 |
work_keys_str_mv | AT kannsivkheng malditofmassspectrometryforsubtypingofstreptococcuspneumoniae AT saosena malditofmassspectrometryforsubtypingofstreptococcuspneumoniae AT phoeungchanleakhena malditofmassspectrometryforsubtypingofstreptococcuspneumoniae AT byyoulet malditofmassspectrometryforsubtypingofstreptococcuspneumoniae AT bryantjuliet malditofmassspectrometryforsubtypingofstreptococcuspneumoniae AT komurianpradelflorence malditofmassspectrometryforsubtypingofstreptococcuspneumoniae AT saphonnvonthanak malditofmassspectrometryforsubtypingofstreptococcuspneumoniae AT choumonidarin malditofmassspectrometryforsubtypingofstreptococcuspneumoniae AT turnerpaul malditofmassspectrometryforsubtypingofstreptococcuspneumoniae |